Furthermore, the extent to which PAI-1 correlates with these pathologies is demonstrated through studies showing that PAI-1 could reliably delineate both the risk of developing T2DM and the severity of the metabolic syndrome [39]. Here, SERPINE1 is linked to metabolic syndrome.